Association between controlling nutritional status score and the prognosis of patients with heart failure: a systematic review and meta-analysis.
Yuan Yuan, Su-Ping Wang, Yi Guan, Qing-Yi Yang et al.
Kernaussage
Elevated Controlling Nutritional Status (CONUT) scores are significantly associated with increased risks of all-cause mortality (HR = 1.57), cardiovascular mortality (HR = 1.53), and heart failure readmission (HR = 1.35) in patients with heart failure.
Abstract
Malnutrition frequently complicates heart failure (HF), interacting with systemic inflammation, metabolic dysregulation, and immune dysfunction to accelerate disease progression. The Controlling Nutritional Status (CONUT) score, derived from objective laboratory parameters (serum albumin, total cholesterol, lymphocyte count), quantifies nutritional derangements and has emerged as a promising tool for HF risk stratification and prognostic prediction. However, accumulating evidence requires systematic synthesis to establish its clinical validity. A comprehensive literature search was conducted in databases including PubMed, Embase, the Cochrane Library and Web of Science, covering all available records up to January 27, 2025, to identify research examining the association between the CONUT score and HF outcomes. The analysis included 28 cohort studies. Pooled data demonstrated a significant correlation between elevated CONUT scores and higher rates of all-cause mortality (HR = 1.57, 95% CI 1.35-1.83; P < 0.00001). Despite substantial heterogeneity, sequential exclusion sensitivity analyses confirmed the robustness of this association, with recalculated estimates consistently showing overlapping confidence intervals across all analytical scenarios. Based on the definition of the CONUT score, malnutrition remains a significant factor associated with overall mortality risk in individuals diagnosed with heart failure, even after controlling for potential confounders. Utilizing the CONUT score for nutritional assessment enables clinicians to detect patients who are more likely to experience unfavorable clinical outcomes. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251023217, PROSPERO CRD420251023217.
Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.
Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.
Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.